window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Medical devices

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Medical devices

    Arkivum partners with PHARMASEAL to enhance unified trial management platform

    Arkivum has announced a partnership with PHARMASEAL, provider of the [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Oral BioLife appoints Greg Ambra as CEO and strengthens leadership team

    Oral BioLife, a regenerative technology company developing non-invasive therapies to [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Terumo BCT expands access to rare disease therapies across Latin America

    Terumo Blood and Cell Technologies has announced regulatory approvals for [...]

    May 5, 2026
  • Clinical & Regulatory,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics

    Amber Implants secures FDA clearance for VCFix spinal system

    Amber Implants has received FDA 510(k) clearance for its VCFix [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    electronRx to launch app for remote respiratory disease management

    electronRx will launch its pDx app at the HLTH 2025 [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    BIG D-FOOT trial results on STIMULAN to be presented at EBJIS 2025

    Biocomposites will present new clinical data from the BIG D-FOOT [...]

    May 5, 2026
  • Clinical & Regulatory,Medical devices,Opinion & Events

    New study shows IntelliSep test improves early sepsis detection and boosts SEP-1 compliance by 29%

    A study presented at the American College of Emergency Physicians [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Living Optics shows real-time hyperspectral imaging on NVIDIA Jetson for blood perfusion insights

    UK company Living Optics has demonstrated real-time blood perfusion imaging [...]

    May 5, 2026
  • Medical devices

    Morphic Medical appoints Jane Wright as chief financial officer during European rollout of Reset

    Appointment strengthens leadership team as company expands access to its [...]

    September 15, 2025
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Medical devices,Pharmaceuticals and therapeutics

    Lithuania sets stage for Life Sciences Baltics with multi-billion-euro investments and AI innovation

    Lithuania’s life sciences sector is preparing to showcase its rapid [...]

    May 5, 2026
Previous789Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA approves Protagonist’s Mimrylo for polycythemia vera, triggering $275M in payments
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics
  • Isomab data support safety of angiogenic approaches in coronary artery disease
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • FDA approves Tivicay PD for children with HIV weighing at least 2kg
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top